Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk
Overview
Overview
Journal
Cardiovasc Intervent Radiol
Specialty
Cardiology & Vascular Diseases
Date
2023 Sep 26
PMID
37750920
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Xu Y, Liu J, Zhang J, Zhuang B, Jia X, Fu W
. Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial. J Vasc Surg. 2021; 74(3):756-762.e3.
DOI: 10.1016/j.jvs.2021.01.041.
View
2.
Teichgraber U, Lehmann T, Ingwersen M, Aschenbach R, Zeller T, Brechtel K
. Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial. Cardiovasc Intervent Radiol. 2022; 45(12):1774-1783.
PMC: 9705448.
DOI: 10.1007/s00270-022-03265-1.
View
3.
Reijnen M, van Wijck I, Brodmann M, Micari A, Torsello G, Rha S
. Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis. Cardiovasc Intervent Radiol. 2023; 46(10):1329-1345.
PMC: 10547845.
DOI: 10.1007/s00270-023-03478-y.
View
4.
Zeller T, Brodmann M, Ansel G, Scheinert D, Choi D, Tepe G
. Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT Global Study. EuroIntervention. 2022; 18(11):e940-e948.
PMC: 9743239.
DOI: 10.4244/EIJ-D-21-01098.
View
5.
Laird J, Schneider P, Jaff M, Brodmann M, Zeller T, Metzger D
. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. Circ Cardiovasc Interv. 2019; 12(6):e007702.
PMC: 6636795.
DOI: 10.1161/CIRCINTERVENTIONS.118.007702.
View